BioSpace News Archive

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, today announced that the database for the Phase III trial of DCVax®-L for Gliobastoma has been locked.

Rapid Reliable Testing (RRT), a subsidiary company of Ambulnz Holdings, LLC, an industry leading on-demand ambulance services provider, partnered with Uber Direct to safely drop off COVID-19 testing packets to residents of New York City

Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce full enrollment of its 200-patient Duo™ Expandable Interbody Fusion (IBF) System Post-Market Study, called RaDical.

Publix Pharmacy announced a new online service for customers who would like to get their flu shot.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, " Single-position prone lateral approach: cadaveric feasibility study and early clinical experience ,” in The Journal of

The connected workflow platform helps specialty practices manage the financial assistance process in a comprehensive, yet streamlined way

During Breast Cancer Awareness Month this October, the National Comprehensive Cancer Network® (NCCN®) is sharing and updating evidence- and expert consensus-based management recommendations which lead to optimal outcomes for people with breast cancer.

KemPharm, Inc. announced that it has expanded its relationship with Corium, Inc. through a new consultation services agreement under which KemPharm will provide product development consultation services to Corium.

The American Red Cross announced a $7.5 million grant from Lilly Endowment Inc., in support of the organization’s disaster relief efforts underway throughout the United States.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that CJ Barnum PhD, Head of Neurosciences will present data from the ongoing biomarker directed Phase Ib study of neuroinflammation in patients with Alzheimer’s disease. The talk entitled, Phase 1b Study in AD Patients with Neuroinflammati